1. Home
  2. ENTA vs CLAR Comparison

ENTA vs CLAR Comparison

Compare ENTA & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTA
  • CLAR
  • Stock Information
  • Founded
  • ENTA 1995
  • CLAR 1957
  • Country
  • ENTA United States
  • CLAR United States
  • Employees
  • ENTA N/A
  • CLAR N/A
  • Industry
  • ENTA Biotechnology: Pharmaceutical Preparations
  • CLAR Recreational Games/Products/Toys
  • Sector
  • ENTA Health Care
  • CLAR Consumer Discretionary
  • Exchange
  • ENTA Nasdaq
  • CLAR Nasdaq
  • Market Cap
  • ENTA 154.0M
  • CLAR 150.4M
  • IPO Year
  • ENTA 2013
  • CLAR N/A
  • Fundamental
  • Price
  • ENTA $5.55
  • CLAR $3.32
  • Analyst Decision
  • ENTA Buy
  • CLAR Strong Buy
  • Analyst Count
  • ENTA 4
  • CLAR 4
  • Target Price
  • ENTA $17.25
  • CLAR $5.50
  • AVG Volume (30 Days)
  • ENTA 178.5K
  • CLAR 200.2K
  • Earning Date
  • ENTA 05-12-2025
  • CLAR 05-08-2025
  • Dividend Yield
  • ENTA N/A
  • CLAR 3.00%
  • EPS Growth
  • ENTA N/A
  • CLAR N/A
  • EPS
  • ENTA N/A
  • CLAR N/A
  • Revenue
  • ENTA $66,590,999.00
  • CLAR $255,437,000.00
  • Revenue This Year
  • ENTA N/A
  • CLAR N/A
  • Revenue Next Year
  • ENTA N/A
  • CLAR $10.96
  • P/E Ratio
  • ENTA N/A
  • CLAR N/A
  • Revenue Growth
  • ENTA N/A
  • CLAR N/A
  • 52 Week Low
  • ENTA $4.09
  • CLAR $3.18
  • 52 Week High
  • ENTA $17.24
  • CLAR $7.24
  • Technical
  • Relative Strength Index (RSI)
  • ENTA 51.08
  • CLAR 43.36
  • Support Level
  • ENTA $4.96
  • CLAR $3.13
  • Resistance Level
  • ENTA $6.23
  • CLAR $3.55
  • Average True Range (ATR)
  • ENTA 0.34
  • CLAR 0.16
  • MACD
  • ENTA 0.01
  • CLAR 0.03
  • Stochastic Oscillator
  • ENTA 46.46
  • CLAR 35.58

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

Share on Social Networks: